Saturday, 15 December 2018
Latest news
Main » GW Pharmaceuticals PLC (GWPH) Expected to Post Earnings of -$1.39 Per Share

GW Pharmaceuticals PLC (GWPH) Expected to Post Earnings of -$1.39 Per Share

03 October 2017

GWPH stock acknowledged attractive focus from Investors and it has been trading on front line. About 4.18M shares traded. DBV Technologies SA - ADR (NASDAQ:DBVT) has risen 16.91% since October 2, 2016 and is uptrending. It has underperformed by 75.40% the S&P500. GW Pharmaceuticals PLC- had a negative net margin of 1,673.22% and a negative return on equity of 48.31%. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. IHT Wealth Management LLC now owns 656 shares of the biopharmaceutical company's stock valued at $108,000 after acquiring an additional 100 shares in the last quarter. The company has market cap of $400.43 million. The stock decreased 0.67% or $0.02 during the last trading session, reaching $2.97. About 2.77M shares traded or 773.78% up from the average.

08/08/2017 - GW Pharmaceuticals Plc was downgraded to "hold" by analysts at Maxim Group. It has outperformed by 0.21% the S&P500. That puts total institutional holdings at 19,636,326 shares, according to SEC filings.

Yesterday GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) traded 1.35% higher at $98.81. Two analysts have issued estimates for GW Pharmaceuticals PLC-'s earnings, with the highest EPS estimate coming in at ($1.15) and the lowest estimate coming in at ($1.80). Below is a list of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) latest ratings and price target changes. During the same period in the previous year, the company earned ($0.05) EPS.

Investors are on alert as GW Pharmaceuticals plc (NASDAQ:GWPH)'s stock is experiencing unusual volume during today's trading. Therefore 83% are positive. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.

Hillary Clinton Blames Las Vegas Attack on NRA
Rather than being apprehended by authorities, the shooter killed himself in a Mandalay Bay hotel room. Multiple GOP leadership aides say there is no House floor vote scheduled yet on that measure.

On average, analysts expect that GW Pharmaceuticals PLC- will report full year earnings of ($5.84) per share for the current year, with EPS estimates ranging from ($7.20) to ($4.53). The rating was maintained by Cantor Fitzgerald with "Buy" on Tuesday, August 8. The rating was initiated by TH Capital with "Buy" on Monday, November 30. The rating was maintained by Cantor Fitzgerald on Monday, December 5 with "Buy". The rating was maintained by Cowen & Co with "Buy" on Monday, September 25. The rating was initiated by Janney Capital on Monday, June 27 with "Sell". Roth Capital maintained GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) rating on Monday, March 14. Maxim Group maintained the shares of GWPH in report on Thursday, June 8 with "Buy" rating. The firm earned "Buy" rating on Thursday, July 6 by H.C. Wainwright. Therefore 88% are positive.

11/29/2016 - GW Pharmaceuticals Plc had its "overweight" rating reiterated by analysts at Piper Jaffray. The company was initiated on Friday, October 7 by Goldman Sachs. As per Wednesday, May 17, the company rating was upgraded by Jefferies. Also, there are 1 buy, 0 sell and 1 strong sell ratings, collectively assigning a 1.81 average brokerage recommendation. Leerink Swann has "Outperform" rating and $153 target. Jefferies maintained the stock with "Buy" rating in Tuesday, August 29 report. More interesting news about ConocoPhillips (NYSE:COP) were released by: and their article: "For ConocoPhillips, Harvey a test of remote operations" published on September 07, 2017 as well as's news article titled: "Strategy To YieldBoost ConocoPhillips From 2.1% To 6% Using Options" with publication date: September 28, 2017.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

GW Pharmaceuticals PLC (GWPH) Expected to Post Earnings of -$1.39 Per Share